286 related articles for article (PubMed ID: 25114586)
1. Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors.
Roy DM; Walsh LA
Breast Cancer (Dove Med Press); 2014; 6():81-91. PubMed ID: 25114586
[TBL] [Abstract][Full Text] [Related]
2. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
Levin M; Udi Y; Solomonov I; Sagi I
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
[TBL] [Abstract][Full Text] [Related]
3. Role of integrins in regulating proteases to mediate extracellular matrix remodeling.
Yue J; Zhang K; Chen J
Cancer Microenviron; 2012 Dec; 5(3):275-83. PubMed ID: 22437309
[TBL] [Abstract][Full Text] [Related]
4. Proteolytic-antiproteolytic balance and its regulation in carcinogenesis.
Skrzydlewska E; Sulkowska M; Koda M; Sulkowski S
World J Gastroenterol; 2005 Mar; 11(9):1251-66. PubMed ID: 15761961
[TBL] [Abstract][Full Text] [Related]
5. TGF-β1 modulates the homeostasis between MMPs and MMP inhibitors through p38 MAPK and ERK1/2 in highly invasive breast cancer cells.
Gomes LR; Terra LF; Wailemann RA; Labriola L; Sogayar MC
BMC Cancer; 2012 Jan; 12():26. PubMed ID: 22260435
[TBL] [Abstract][Full Text] [Related]
6. Extracellular proteases as targets for treatment of cancer metastases.
Lee M; Fridman R; Mobashery S
Chem Soc Rev; 2004 Sep; 33(7):401-9. PubMed ID: 15354221
[TBL] [Abstract][Full Text] [Related]
7. Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential.
Figueira RC; Gomes LR; Neto JS; Silva FC; Silva ID; Sogayar MC
BMC Cancer; 2009 Jan; 9():20. PubMed ID: 19144199
[TBL] [Abstract][Full Text] [Related]
8. [Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis].
Masson V
Bull Mem Acad R Med Belg; 2006; 161(5):320-6. PubMed ID: 17283905
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions.
Siddhartha R; Garg M
Toxicol Appl Pharmacol; 2021 Sep; 426():115593. PubMed ID: 34038713
[TBL] [Abstract][Full Text] [Related]
10. Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis.
Yuzhalin AE; Lim SY; Kutikhin AG; Gordon-Weeks AN
Biochim Biophys Acta Rev Cancer; 2018 Dec; 1870(2):207-228. PubMed ID: 30316942
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of proteases as anticancer drugs.
Jedinak A; Maliar T
Neoplasma; 2005; 52(3):185-92. PubMed ID: 15875078
[TBL] [Abstract][Full Text] [Related]
12. Ovarian tissue remodeling: role of matrix metalloproteinases and their inhibitors.
Smith MF; Ricke WA; Bakke LJ; Dow MP; Smith GW
Mol Cell Endocrinol; 2002 May; 191(1):45-56. PubMed ID: 12044918
[TBL] [Abstract][Full Text] [Related]
13. Cardiac remodeling and failure From molecules to man (Part II).
Fedak PW; Verma S; Weisel RD; Li RK
Cardiovasc Pathol; 2005; 14(2):49-60. PubMed ID: 15780796
[TBL] [Abstract][Full Text] [Related]
14. Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair.
Paiva KBS; Granjeiro JM
Prog Mol Biol Transl Sci; 2017; 148():203-303. PubMed ID: 28662823
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Gelatinases (MMP-2 and MMP-9 by Gelatin Zymography.
Toth M; Fridman R
Methods Mol Med; 2001; 57():163-74. PubMed ID: 21340898
[TBL] [Abstract][Full Text] [Related]
16. Gastric cancer - The role of matrix metalloproteinases in tumor progression.
Lukaszewicz-Zając M; Mroczko B; Szmitkowski M
Clin Chim Acta; 2011 Sep; 412(19-20):1725-30. PubMed ID: 21693112
[TBL] [Abstract][Full Text] [Related]
17. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
Liu J; Khalil RA
Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
[TBL] [Abstract][Full Text] [Related]
18. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
19. Modulation of uPA, MMPs and their inhibitors by a novel nutrient mixture in human glioblastoma cell lines.
Roomi MW; Kalinovsky T; Niedzwiecki A; Rath M
Int J Oncol; 2014 Aug; 45(2):887-94. PubMed ID: 24867464
[TBL] [Abstract][Full Text] [Related]
20. Extracellular matrix communication and turnover in cardiac physiology and pathology.
Takawale A; Sakamuri SS; Kassiri Z
Compr Physiol; 2015 Apr; 5(2):687-719. PubMed ID: 25880510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
